Asset Details
Do you wish to reserve the book?
A Probable Dual Mode of Action for Both L- and D-Lactate Neuroprotection in Cerebral Ischemia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Probable Dual Mode of Action for Both L- and D-Lactate Neuroprotection in Cerebral Ischemia
Do you wish to request the book?
A Probable Dual Mode of Action for Both L- and D-Lactate Neuroprotection in Cerebral Ischemia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Probable Dual Mode of Action for Both L- and D-Lactate Neuroprotection in Cerebral Ischemia
2015
Overview
Lactate has been shown to offer neuroprotection in several pathologic conditions. This beneficial effect has been attributed to its use as an alternative energy substrate. However, recent description of the expression of the HCA1 receptor for lactate in the central nervous system calls for reassessment of the mechanism by which lactate exerts its neuroprotective effects. Here, we show that HCA1 receptor expression is enhanced 24 hours after reperfusion in an middle cerebral artery occlusion stroke model, in the ischemic cortex. Interestingly, intravenous injection of L-lactate at reperfusion led to further enhancement of HCA1 receptor expression in the cortex and striatum. Using an in vitro oxygen-glucose deprivation model, we show that the HCA1 receptor agonist 3,5-dihydroxybenzoic acid reduces cell death. We also observed that D-lactate, a reputedly non-metabolizable substrate but partial HCA1 receptor agonist, also provided neuroprotection in both in vitro and in vivo ischemia models. Quite unexpectedly, we show D-lactate to be partly extracted and oxidized by the rodent brain. Finally, pyruvate offered neuroprotection in vitro whereas acetate was ineffective. Our data suggest that L- and D-lactate offer neuroprotection in ischemia most likely by acting as both an HCA1 receptor agonist for non-astrocytic (most likely neuronal) cells as well as an energy substrate.
Publisher
SAGE Publications,Sage Publications Ltd,Nature Publishing Group
Subject
/ Behavior, Animal - drug effects
/ Brain Chemistry - drug effects
/ Brain Ischemia - drug therapy
/ Carrier Proteins - biosynthesis
/ Kinetics
/ Lactic Acid - therapeutic use
/ Male
/ Mice
/ Nerve Tissue Proteins - biosynthesis
/ Nerve Tissue Proteins - genetics
/ Neuroprotective Agents - therapeutic use
/ Original
